Lv4
610 积分 2023-02-15 加入
Therapeutic resistance to anti-oestrogen therapy in breast cancer
1年前
已完结
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
1年前
已完结
The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics
1年前
已完结
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
1年前
已完结
Factor XI inhibitors in patients with cardiovascular disease and a high risk of bleeding: a cautionary tale
1年前
已关闭
Hypertension in China: epidemiology and treatment initiatives
1年前
已完结
A guide to thymic selection of T cells
1年前
已完结
The emerging family of RORγt+ antigen-presenting cells
1年前
已完结
Disease modification in inflammatory skin disorders: opportunities and challenges
1年前
已完结
Cholangiocarcinoma — novel biological insights and therapeutic strategies
1年前
已完结
皖公网安备34019202002308
